Regner KR and Roman RJ |
Role of medullary blood flow in the pathogenesis of renal ischemia-reperfusion injury. |
2012 |
Curr. Opin. Nephrol. Hypertens. |
pmid:22080855
|
Theken KN et al. |
Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease. |
2012 |
Atherosclerosis |
pmid:22503544
|
Liu X et al. |
Disturbed ratio of renal 20-HETE/EETs is involved in androgen-induced hypertension in cytochrome P450 4F2 transgenic mice. |
2012 |
Gene |
pmid:22387726
|
Renic M et al. |
Protective effect of 20-HETE inhibition in a model of oxygen-glucose deprivation in hippocampal slice cultures. |
2012 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:22245774
|
Nikolaeva S et al. |
The circadian clock modulates renal sodium handling. |
2012 |
J. Am. Soc. Nephrol. |
pmid:22440902
|
Williams JM et al. |
Role of 20-HETE in the antihypertensive effect of transfer of chromosome 5 from Brown Norway to Dahl salt-sensitive rats. |
2012 |
Am. J. Physiol. Regul. Integr. Comp. Physiol. |
pmid:22442195
|
Jacobs ER et al. |
Tissue protection and endothelial cell signaling by 20-HETE analogs in intact ex vivo lung slices. |
2012 |
Exp. Cell Res. |
pmid:22687879
|
Kawasaki T et al. |
Increase of 20-HETE synthase after brain ischemia in rats revealed by PET study with 11C-labeled 20-HETE synthase-specific inhibitor. |
2012 |
J. Cereb. Blood Flow Metab. |
pmid:22669478
|
Wen H et al. |
20-Hydroxyeicosatetraenoic acid (20-HETE) is a novel activator of transient receptor potential vanilloid 1 (TRPV1) channel. |
2012 |
J. Biol. Chem. |
pmid:22389490
|
Tunctan B et al. |
A novel treatment strategy for sepsis and septic shock based on the interactions between prostanoids, nitric oxide, and 20-hydroxyeicosatetraenoic acid. |
2012 |
Antiinflamm Antiallergy Agents Med Chem |
pmid:23013331
|
Ward NC et al. |
Cytochrome P450 metabolites of arachidonic acid are elevated in stroke patients compared with healthy controls. |
2011 |
Clin. Sci. |
pmid:21689071
|
Sridar C et al. |
Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6. |
2011 |
Drug Metab. Dispos. |
pmid:21289075
|
Liu X et al. |
Epoxyeicosatrienoic acid-dependent cerebral vasodilation evoked by metabotropic glutamate receptor activation in vivo. |
2011 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:21602473
|
Liang CJ et al. |
20-Hydroxyeicosatetraenoic acid inhibits ATP-induced COX-2 expression via peroxisome proliferator activator receptor-α in vascular smooth muscle cells. |
2011 |
Br. J. Pharmacol. |
pmid:21323895
|
Xie XN et al. |
[Progress in research of arachidonic acid-cytochrome P450 pathway in diabetes]. |
2011 |
Sheng Li Ke Xue Jin Zhan |
pmid:22066421
|
Boonprasert K et al. |
Study on the association between environmental cadmium exposure, cytochrome P450-mediated 20-HETE, heme-oxygenase-1 polymorphism and hypertension in Thai population residing in a malaria endemic areas with cadmium pollution. |
2011 |
Environ. Toxicol. Pharmacol. |
pmid:21787712
|
Pat Kunert M and Drenjancević I |
20-hydroxyeicosatetraenoic acid, endothelial dysfunction and hypertension. |
2011 |
Med Glas (Zenica) |
pmid:21849935
|
Wu CC and Schwartzman ML |
The role of 20-HETE in androgen-mediated hypertension. |
2011 |
Prostaglandins Other Lipid Mediat. |
pmid:21722750
|
Imig JD et al. |
Cytochrome P450 eicosanoids and cerebral vascular function. |
2011 |
Expert Rev Mol Med |
pmid:21356152
|
Sacerdoti D et al. |
11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension. |
2011 |
Prostaglandins Other Lipid Mediat. |
pmid:21856435
|
Hoff U et al. |
Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury. |
2011 |
Kidney Int. |
pmid:20962739
|
Roman RJ et al. |
20-HETE in acute kidney injury. |
2011 |
Kidney Int. |
pmid:21157458
|
Speed JS et al. |
Role of 20-hydroxyeicosatetraenoic acid in mediating hypertension in response to chronic renal medullary endothelin type B receptor blockade. |
2011 |
PLoS ONE |
pmid:22016812
|
Kuczeriszka M et al. |
Interaction of nitric oxide and the cytochrome P-450 system on blood pressure and renal function in the rat: dependence on sodium intake. |
2011 |
Acta Physiol (Oxf) |
pmid:21073660
|
Hu BC et al. |
Peripheral and central augmentation indexes in relation to the CYP4F2 polymorphisms in Chinese. |
2011 |
J. Hypertens. |
pmid:21150635
|
Baragatti B and Coceani F |
Arachidonic acid epoxygenase and 12(S)-lipoxygenase: evidence of their concerted involvement in ductus arteriosus constriction to oxygen. |
2011 |
Can. J. Physiol. Pharmacol. |
pmid:21619415
|
Wang Z et al. |
Inhibition of 20-HETE attenuates diabetes-induced decreases in retinal hemodynamics. |
2011 |
Exp. Eye Res. |
pmid:21658386
|
Ward NC et al. |
Chronic activation of AMP-activated protein kinase prevents 20-hydroxyeicosatetraenoic acid-induced endothelial dysfunction. |
2011 |
Clin. Exp. Pharmacol. Physiol. |
pmid:21388435
|
Wu CC et al. |
Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB Kinase. |
2011 |
Hypertension |
pmid:21321301
|
Sporková A et al. |
Role of cytochrome P-450 metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive rats. |
2011 |
Am. J. Physiol. Regul. Integr. Comp. Physiol. |
pmid:21411763
|
Yanes LL et al. |
Postmenopausal hypertension: role of 20-HETE. |
2011 |
Am. J. Physiol. Regul. Integr. Comp. Physiol. |
pmid:21474427
|
Guo AM et al. |
The cytochrome P450 4A/F-20-hydroxyeicosatetraenoic acid system: a regulator of endothelial precursor cells derived from human umbilical cord blood. |
2011 |
J. Pharmacol. Exp. Ther. |
pmid:21527533
|
Buharalioglu CK et al. |
Piroxicam reverses endotoxin-induced hypotension in rats: contribution of vasoactive eicosanoids and nitric oxide. |
2011 |
Basic Clin. Pharmacol. Toxicol. |
pmid:21463481
|
Bao Y et al. |
20-Hydroxyeicosatetraenoic acid induces apoptosis in neonatal rat cardiomyocytes through mitochondrial-dependent pathways. |
2011 |
J. Cardiovasc. Pharmacol. |
pmid:21266918
|
Harder DR et al. |
Pressure-induced myogenic tone and role of 20-HETE in mediating autoregulation of cerebral blood flow. |
2011 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:21257913
|
Tsai IJ et al. |
20-Hydroxyeicosatetraenoic acid synthesis is increased in human neutrophils and platelets by angiotensin II and endothelin-1. |
2011 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:21239640
|
Toth P et al. |
Isolated human and rat cerebral arteries constrict to increases in flow: role of 20-HETE and TP receptors. |
2011 |
J. Cereb. Blood Flow Metab. |
pmid:21610722
|
Crago EA et al. |
Cerebrospinal fluid 20-HETE is associated with delayed cerebral ischemia and poor outcomes after aneurysmal subarachnoid hemorrhage. |
2011 |
Stroke |
pmid:21617146
|
Arnold C et al. |
Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids. |
2010 May-Jun |
Pharmacol Rep |
pmid:20631419
|
Dolegowska B et al. |
Lipoxygenase-derived hydroxyeicosatetraenoic acids--novel perioperative markers of early post-transplant allograft function? |
2010 |
Nephrol. Dial. Transplant. |
pmid:20530808
|
Yang X et al. |
The effects of a lupin-enriched diet on oxidative stress and factors influencing vascular function in overweight subjects. |
2010 |
Antioxid. Redox Signal. |
pmid:20214496
|
Cheng J et al. |
20-hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling. |
2010 |
J. Pharmacol. Exp. Ther. |
pmid:19841472
|
Zordoky BN et al. |
Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats. |
2010 |
Toxicol. Appl. Pharmacol. |
pmid:19796650
|
Cuez T et al. |
A synthetic analogue of 20-HETE, 5,14-HEDGE, reverses endotoxin-induced hypotension via increased 20-HETE levels associated with decreased iNOS protein expression and vasodilator prostanoid production in rats. |
2010 |
Basic Clin. Pharmacol. Toxicol. |
pmid:20002062
|
Devos A et al. |
Genetic polymorphism of CYP2U1, a cytochrome P450 involved in fatty acids hydroxylation. |
2010 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:20630735
|
Schäfer A et al. |
Increased cytochrome P4502E1 expression and altered hydroxyeicosatetraenoic acid formation mediate diabetic vascular dysfunction: rescue by guanylyl-cyclase activation. |
2010 |
Diabetes |
pmid:20522591
|
Bodiga S et al. |
20-HETE-induced nitric oxide production in pulmonary artery endothelial cells is mediated by NADPH oxidase, H2O2, and PI3-kinase/Akt. |
2010 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:20061439
|
Anwar-mohamed A et al. |
Alteration of cardiac cytochrome P450-mediated arachidonic acid metabolism in response to lipopolysaccharide-induced acute systemic inflammation. |
2010 |
Pharmacol. Res. |
pmid:20045729
|
Cooper PR et al. |
20-HETE mediates ozone-induced, neutrophil-independent airway hyper-responsiveness in mice. |
2010 |
PLoS ONE |
pmid:20422032
|
Raffai G et al. |
Modulation by cytochrome P450-4A ω-hydroxylase enzymes of adrenergic vasoconstriction and response to reduced PO₂ in mesenteric resistance arteries of Dahl salt-sensitive rats. |
2010 |
Microcirculation |
pmid:21040118
|
Zeng Q et al. |
20-HETE increases NADPH oxidase-derived ROS production and stimulates the L-type Ca2+ channel via a PKC-dependent mechanism in cardiomyocytes. |
2010 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:20675568
|
Ljuca F and Drevensek G |
Endothelin-1 induced vascular smooth muscle cell proliferation is mediated by cytochrome p-450 arachidonic acid metabolites. |
2010 |
Bosn J Basic Med Sci |
pmid:20846129
|
Sahan-Firat S et al. |
2,3',4,5'-Tetramethoxystilbene prevents deoxycorticosterone-salt-induced hypertension: contribution of cytochrome P-450 1B1. |
2010 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:20852048
|
CertÃková Chábová V et al. |
Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats. |
2010 |
Clin. Sci. |
pmid:20050826
|
Sodhi K et al. |
CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent. |
2010 |
Hypertension |
pmid:20837888
|
Marumo T et al. |
The inhibitor of 20-HETE synthesis, TS-011, improves cerebral microcirculatory autoregulation impaired by middle cerebral artery occlusion in mice. |
2010 |
Br. J. Pharmacol. |
pmid:20735406
|
Yousif MH and Benter IF |
Role of 20-hydroxyeicosatetraenoic and epoxyeicosatrienoic acids in the regulation of vascular function in a model of hypertension and endothelial dysfunction. |
2010 |
Pharmacology |
pmid:20699631
|
Liu JY et al. |
Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events. |
2010 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:20837537
|
Imig JD |
20-hydroxyeicosatetraenoic acid and angiotensin: a positive feedback system to cause hypertension. |
2010 |
Hypertension |
pmid:20837886
|
Bardowell SA et al. |
Common variants of cytochrome P450 4F2 exhibit altered vitamin E-{omega}-hydroxylase specific activity. |
2010 |
J. Nutr. |
pmid:20861217
|
Williams JM et al. |
20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension. |
2010 |
J. Cardiovasc. Pharmacol. |
pmid:20930591
|
Fidelis P et al. |
Renal function and vasomotor activity in mice lacking the Cyp4a14 gene. |
2010 |
Exp. Biol. Med. (Maywood) |
pmid:20943934
|
Liu X et al. |
Overexpression of cytochrome P450 4F2 in mice increases 20-hydroxyeicosatetraenoic acid production and arterial blood pressure. |
2009 |
Kidney Int. |
pmid:19279555
|
Yousif MH et al. |
Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes. |
2009 |
Auton Autacoid Pharmacol |
pmid:19302551
|
Hilgers RH and De Mey JG |
Myoendothelial coupling in the mesenteric arterial bed; segmental differences and interplay between nitric oxide and endothelin-1. |
2009 |
Br. J. Pharmacol. |
pmid:19302591
|
Inoue R et al. |
Chemical-mechanical synergism for cardiovascular TRPC6 channel activation via PLC/diacylglycerol and PLA2/omega-hydroxylase/20-HETE pathways. |
2009 |
Nippon Yakurigaku Zasshi |
pmid:19749481
|
Kunert MP et al. |
CYP450 4A inhibition attenuates O2 induced arteriolar constriction in chronic but not acute Goldblatt hypertension. |
2009 |
Microvasc. Res. |
pmid:19761780
|
Tsai IJ et al. |
20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction. |
2009 |
Free Radic. Biol. Med. |
pmid:19013235
|
Regner KR et al. |
Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury. |
2009 |
Kidney Int. |
pmid:19052533
|
Dhanasekaran A et al. |
20-HETE increases survival and decreases apoptosis in pulmonary arteries and pulmonary artery endothelial cells. |
2009 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:19136601
|
Nayeem MA et al. |
High-salt diet enhances mouse aortic relaxation through adenosine A2A receptor via CYP epoxygenases. |
2009 |
Am. J. Physiol. Regul. Integr. Comp. Physiol. |
pmid:19109366
|
Renic M et al. |
Effect of 20-HETE inhibition on infarct volume and cerebral blood flow after transient middle cerebral artery occlusion. |
2009 |
J. Cereb. Blood Flow Metab. |
pmid:19107134
|
Inoue R et al. |
Synergistic activation of vascular TRPC6 channel by receptor and mechanical stimulation via phospholipase C/diacylglycerol and phospholipase A2/omega-hydroxylase/20-HETE pathways. |
2009 |
Circ. Res. |
pmid:19443836
|
Cai Y |
Arachidonic acid cytochrome P450 4F2 in hypertension: what can we learn from a transgenic mouse model?? |
2009 |
Kidney Int. |
pmid:19483747
|
Zhang Y et al. |
The role of 20-hydroxyeicosatetraenoic acid in adrenocorticotrophic hormone and dexamethasone-induced hypertension. |
2009 |
J. Hypertens. |
pmid:19458537
|
Guo AM et al. |
20-HETE can act as a nonhypoxic regulator of HIF-1alpha in human microvascular endothelial cells. |
2009 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:19502554
|
Akbulut T et al. |
20-HETE activates the Raf/MEK/ERK pathway in renal epithelial cells through an EGFR- and c-Src-dependent mechanism. |
2009 |
Am. J. Physiol. Renal Physiol. |
pmid:19570883
|
Inoue K et al. |
Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE. |
2009 |
Am. J. Physiol. Renal Physiol. |
pmid:19675180
|
Liclican EL et al. |
Inhibition of the adenosine2A receptor-epoxyeicosatrienoic acid pathway renders Dahl salt-resistant rats hypertensive. |
2009 |
Hypertension |
pmid:19822802
|
Hama-Tomioka K et al. |
The role of 20-hydroxyeicosatetraenoic acid in cerebral arteriolar constriction and the inhibitory effect of propofol. |
2009 |
Anesth. Analg. |
pmid:19923524
|
Alexanian A et al. |
Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growth. |
2009 |
Anticancer Res. |
pmid:19846914
|
Wu JH et al. |
Inhibition of 20-hydroxyeicosatetraenoic acid synthesis using specific plant lignans: in vitro and human studies. |
2009 |
Hypertension |
pmid:19786646
|
Fava C et al. |
Overexpression of cytochrome P450 4F2 in mice increases 20-hydroxyeicosatetraenoic acid production and arterial blood pressure. |
2009 |
Kidney Int. |
pmid:19789547
|
Yousif MH et al. |
Cytochrome P450 metabolites of arachidonic acid play a role in the enhanced cardiac dysfunction in diabetic rats following ischaemic reperfusion injury. |
2009 |
Auton Autacoid Pharmacol |
pmid:19302554
|
Gu RM et al. |
CYP-omega-hydroxylation-dependent metabolites of arachidonic acid inhibit the basolateral 10 pS chloride channel in the rat thick ascending limb. |
2009 |
Kidney Int. |
pmid:19641481
|
Park F et al. |
Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD. |
2009 |
Am. J. Physiol. Renal Physiol. |
pmid:19129252
|
Luo P et al. |
Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy. |
2009 |
Am. J. Physiol. Renal Physiol. |
pmid:19129258
|
Miller TM et al. |
Rapid, simultaneous quantitation of mono and dioxygenated metabolites of arachidonic acid in human CSF and rat brain. |
2009 |
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. |
pmid:19892608
|
Rimmerman N et al. |
Microsomal omega-hydroxylated metabolites of N-arachidonoyl dopamine are active at recombinant human TRPV1 receptors. |
2009 |
Prostaglandins Other Lipid Mediat. |
pmid:18812233
|
Wang J et al. |
Modulation of vascular O2 responses by cytochrome 450-4A omega-hydroxylase metabolites in Dahl salt-sensitive rats. |
2009 |
Microcirculation |
pmid:19225982
|
Hamilton SJ et al. |
Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients. |
2009 |
Diabetes Care |
pmid:19228872
|
Eid AA et al. |
Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. |
2009 |
Diabetes |
pmid:19208908
|
Dołegowska B et al. |
Is it possible to predict the early post-transplant allograft function using 20-HETE measurements? A preliminary report. |
2009 |
Transpl. Int. |
pmid:19175563
|
Cao S et al. |
Endothelin rather than 20-HETE contributes to loss of pial arteriolar dilation during focal cerebral ischemia with and without polymeric hemoglobin transfusion. |
2009 |
Am. J. Physiol. Regul. Integr. Comp. Physiol. |
pmid:19261918
|
Singh H and Schwartzman ML |
Renal vascular cytochrome P450-derived eicosanoids in androgen-induced hypertension. |
2008 Jan-Feb |
Pharmacol Rep |
pmid:18276983
|
Yang HY and Chen JR |
Renoprotective effects of soy protein hydrolysates in N(omega)-nitro-L-arginine methyl ester hydrochloride-induced hypertensive rats. |
2008 |
Hypertens. Res. |
pmid:18957819
|
Fava C et al. |
The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure. |
2008 |
Hypertension |
pmid:18574070
|
Guo AM et al. |
Expression of CYP4A1 in U251 human glioma cell induces hyperproliferative phenotype in vitro and rapidly growing tumors in vivo. |
2008 |
J. Pharmacol. Exp. Ther. |
pmid:18591218
|
Fu Z et al. |
Haplotype-based case study of human CYP4A11 gene and cerebral infarction in Japanese subject. |
2008 |
Endocrine |
pmid:18484194
|
Mu Y et al. |
Intravenous formulation of N-hydroxy-N'-(4-n-butyl-2-methylphenyl)formamidine (HET0016) for inhibition of rat brain 20-hydroxyeicosatetraenoic acid formation. |
2008 |
Drug Metab. Dispos. |
pmid:18725506
|